Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-01-27 | Dr. Eisenberger is a medical professor and researcher with no indication of software engineering or programming experience. |
| 2018-01-26 | Dr. Eisenberger’s medical background and broad business experience in the pharmaceutical industry. |
| 2019-01-28 | Dr. Eisenberger obtained his M.D. at the Federal University of Rio de Janeiro Brazil in 1972 and is board certified in Internal Medicine and Medical Oncology. |
| 2020-01-28 | Dr. Eisenberger obtained his M.D. at the Federal University of Rio de Janeiro Brazil in 1972 and is board certified in Internal Medicine and Medical Oncology. |
| 2021-01-28 | Dr. Eisenberger obtained his M.D. at the Federal University of Rio de Janeiro Brazil in 1972 and is board certified in Internal Medicine and Medical Oncology. |
| 2022-01-28 | Dr. Eisenberger obtained his M.D. at the Federal University of Rio de Janeiro Brazil in 1972 and is board certified in Internal Medicine and Medical Oncology. |
| 2023-01-27 | Dr. Eisenberger obtained his M.D. at the Federal University of Rio de Janeiro Brazil in 1972 and is board certified in Internal Medicine and Medical Oncology. |
| 2023-06-12 | Mario Eisenberger, M.D. (8) Consists of 180,001 shares of Common Stock subject to stock options. |
| 2024-01-26 | Dr. Eisenberger obtained his M.D. at the Federal University of Rio de Janeiro Brazil in 1972 and is board certified in Internal Medicine and Medical Oncology. |
Data sourced from SEC filings. Last updated: 2025-08-30